Pulmonary Fibrosis Foundation Offers Clinical Trial Update Webinar

May 18, 2014 9:00 PM

17 0

Results from Boehringer Ingelheim, InterMune and IPFnet clinical trials discussed

WHO: The Pulmonary Fibrosis Foundation (PFF) will discuss results from recent idiopathic pulmonary fibrosis (IPF) clinical trials in an upcoming webinar. Boehringer Ingelheim and InterMune both recently released data from their Phase III randomized, placebo-controlled trials, each demonstrating eff...

Read more

To category page